Literature DB >> 35035051

Hemophagocytic lymphohistiocytosis in a child with chronic granulomatous disease: A rare complication of a rare disorder.

Gitanjali Jain1, Suprita Kalra2, Saurabh Sharma3, Gautam Kumar Vasnik4, Rakesh Gupta5.   

Abstract

Chronic Granulomatous Disease (CGD) is a primary immunodeficiency disorder (PID) of phagocytic cells resulting in failure to eradicate catalase positive microorganisms like Staphylococci and fungal infections; due to deficiency or malfunction of nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase subunits in phagocytic leucocytes. We illustrate here one such case; a six year old girl who was admitted in our hospital with history of prolonged fever, non resolving bilateral otitis media and recurrent pneumonia. She was evaluated for an underlying PID and was found to have CGD based on Nitro blue Tetrazolium (NBT) Slide Test and flow cytometric Dihydrorhodamine (DHR) assay. The child was symptomatic despite initial treatment with first-line followed by second-line antibiotics. During the course of current systemic infection, she also developed infection-associated secondary Hemophagocytic Lympho Histiocytosis (HLH) as suggested by her clinical and laboratory parameters. Despite a thorough search, no microorganism could be isolated and so she was treated with empircal antibiotic therapy comprising of meropenem, linezolid and an antifungal. Fever resolved with gradual improvement of laboratory parameters and finally spontaneous resolution of HLH. We conclude that a high index of suspicion for PID is required in a child with recurrent infections. Identification of underlying infectious agent should be attempted to start targeted antimicrobial therapy; both to prevent as well as cure infection associated secondary HLH.
© 2019 Armed Forces Medical Services (AFMS).

Entities:  

Keywords:  Bone marrow; Chronic granulomatous disease; Hemophagocytic lymphohistiocytosis; Immunodeficiency disorder; Infection

Year:  2019        PMID: 35035051      PMCID: PMC8737091          DOI: 10.1016/j.mjafi.2018.11.012

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease.

Authors:  Aristóteles Álvarez-Cardona; Ana Luisa Rodríguez-Lozano; Lizbeth Blancas-Galicia; Francisco Eduardo Rivas-Larrauri; Marco A Yamazaki-Nakashimada
Journal:  J Clin Immunol       Date:  2011-11-26       Impact factor: 8.317

3.  Hemophagocytic syndrome in a 4-month-old infant with biotinidase deficiency.

Authors:  Fatih Kardas; Turkan Patiroglu; Ekrem Unal; Samuel C C Chiang; Yenan T Bryceson; Mustafa Kendirci
Journal:  Pediatr Blood Cancer       Date:  2011-08-16       Impact factor: 3.167

4.  Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease.

Authors:  Chintan Parekh; Thomas Hofstra; Joseph A Church; Thomas D Coates
Journal:  Pediatr Blood Cancer       Date:  2010-11-11       Impact factor: 3.167

5.  The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.

Authors:  Sebastian Fn Bode; Sandra Ammann; Waleed Al-Herz; Mihaela Bataneant; Christopher C Dvorak; Stephan Gehring; Andrew Gennery; Kimberly C Gilmour; Luis I Gonzalez-Granado; Ute Groß-Wieltsch; Marianne Ifversen; Jenny Lingman-Framme; Susanne Matthes-Martin; Rolf Mesters; Isabelle Meyts; Joris M van Montfrans; Jana Pachlopnik Schmid; Sung-Yun Pai; Pere Soler-Palacin; Uta Schuermann; Volker Schuster; Markus G Seidel; Carsten Speckmann; Polina Stepensky; Karl-Walter Sykora; Bianca Tesi; Thomas Vraetz; Catherine Waruiru; Yenan T Bryceson; Despina Moshous; Kai Lehmberg; Michael B Jordan; Stephan Ehl
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

6.  Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: a case report.

Authors:  Gregory Valentine; Tessy A Thomas; Trung Nguyen; Yi-Chen Lai
Journal:  Pediatrics       Date:  2014-12       Impact factor: 7.124

Review 7.  Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis.

Authors:  Smita Ramachandran; Fauzia Zaidi; Archana Aggarwal; Rani Gera
Journal:  Blood Cells Mol Dis       Date:  2016-11-03       Impact factor: 3.039

Review 8.  Modern management of chronic granulomatous disease.

Authors:  Reinhard A Seger
Journal:  Br J Haematol       Date:  2008-02       Impact factor: 6.998

9.  Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease.

Authors:  Michi Hisano; Kana Sugawara; Osamu Tatsuzawa; Michihiro Kitagawa; Atsuko Murashima; Koushi Yamaguchi
Journal:  J Med Microbiol       Date:  2007-05       Impact factor: 2.472

Review 10.  A Review of Chronic Granulomatous Disease.

Authors:  Danielle E Arnold; Jennifer R Heimall
Journal:  Adv Ther       Date:  2017-11-22       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.